DMTweet (& vote for our SXSW panel)
a tweet recap by PsyMed Ventures x Business Trip colab (issue #11)
πππππππππππππππππ
First, a quick favor: Please vote for our three SXSW panels.
This will help us get on stage at SXSW 2023! Today is the last day of voting:
#1: A psychedelic industry overview presentation: Vote here
#2: Panel about how psychedelic medicine can integrate into the healthcare system:
Vote here
#3: Larger Promise of Psychedelics: Beyond Depression: Vote here
We appreciate your support :)
To vote, create a SXSW account and click the β¬οΈ arrow in the top right corner (takes 2 minutes!)
πππππππππππππππππ
DMTweet is a newsletter of psychedelic tweets that catch our eye π.
This is a collaboration betweenΒ PsyMed VenturesΒ andΒ Business TripΒ (yes, weβre the folks working on both π).
Tweets include: Industry updates πΌ, Therapy ποΈ, Psychedelic research π§ͺ, Neuroscience π§ , Consciousness β¨, Indigenous reciprocity βοΈ, Regulatory updates π, and Trippy ideas π½.
Inclusion = interesting β endorsement.
Letβs get to itβ¦.
Until next time,
πππππππππππππππππ
DMTweet is a collab between PsyMed Ventures and Business Trip. PsyMed Ventures is a community-focusedΒ fundΒ andΒ syndicateΒ investing in psychedelic medicine and mental health tech.Β Business TripΒ is a podcast about psychedelic entrepreneurship. Our mission is to help expand access to psychedelic medicine and mental health.